People

  1. Verma
    Verma
  2. Windner
    Windner
  3. Zhang
    Zhang
  4. Liang
    Liang
  5. Korc-Grodzicki
    Korc-Grodzicki
  6. Fernandes De Paula Tito Jorge
    Fernandes De Paula Tito Jorge
  7. Keesing
    Keesing
  8. Bellis
    Bellis
  9. Anderson
    Anderson
  10. Williams
    Williams
  11. Yu
    Yu
  12. Wang
    Wang
  13. Hadjantonakis
    Hadjantonakis
  14. Gavrilovic
    Gavrilovic
  15. McCullagh
    McCullagh

Recent Works

  1. Clinical characteristics and treatment outcomes in patients with histiocytic neoplasms harboring class 3 MAP2K1 mutations, including novel treatment with the ERK inhibitor ulixertinib
    Meeting Abstract

    Diamond, E. L.; Rosenblum, M.; Yabe, M.; Petrova-Drus, K.; Francis, J. H.; Rampal, R. K.; Lacouture, M. E.; Rotemberg, V. M.; Hatzoglou, V.; Young, R.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  2. CAR-associated hemophagocytic lymphohistiocytosis (carHLH) is associated with pre-infusion inflammation and high disease burden and predicts poor outcomes following tisagenlecleucel in pediatric B-ALL
    Meeting Abstract

    McNerney, K. O.; Lim, S. S.; Ishikawa, K.; Dreyzin, A.; Vatsayan, A.; Chen, J. J.; Baggott, C.; Prabhu, S.; Pacenta, H.; Philips, C.; more...
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save
  3. Efficacy of alpelisib in PI3K-driven langerhans cell histiocytosis
    Meeting Abstract

    Mazor, R. D.; Durham, B. H.; Abdel-Wahab, O. I.; Diamond, E. L.; Yabe, M.; Itchaki, G.; Ben-Sasson, M.; Hershkovitz-Rokah, O.; Shpilberg, O.
    Pediatric Blood and Cancer (2023)

    Fulltext@MSK | Save